Neuroblastoma in Iran: An Experience of 32 Years at a Referral Childrens Hospital |
Mehdiabadi, Gholamreza Bahoush
(Onco-Pathology Research Center, Ali-Asghar Children Hospital)
Arab, Elaheh (Iran University of Medical Sciences) Rafsanjani, Khadijeh Arjmandi (Iran University of Medical Sciences) Ansari, Shahla (Iran University of Medical Sciences) Moinzadeh, Amir Majid (Farzan Clinical Research Institute) |
1 | Harder T, Plagemann A, Harder A (2010). Birth weight and risk of neuroblastoma:a meta-analysis. Int J Epidemiol, 39, 746-56. DOI ScienceOn |
2 | Henderson TO, Bhatia S, Pinto N, et al (2011). Racial and ethnic disparities in risk and survival in children with neuroblastoma: a children's oncology group study. J Clin Oncol, 29, 76-82. DOI ScienceOn |
3 | Hiyama E (2008). Neuroblastoma screening in Japan: populationbased cohort study and future aspects of screening. Ann Acad Med Singapore, 37, 88-91. |
4 | Lee A (2012). Neuroblastoma: the challenge remains. Singapore Med J, 53, 1-2. |
5 | Ries LAG, Krapcho M, Mariotto A, et al (2007). SEER cancer statistics review, 1975-2004. National Cancer Institute, 2007. |
6 | Schilling FH, Spix C, Berthold F, et al (2002). Neuroblastoma screening at one year of age. N Engl J Med, 346, 1047-53. DOI ScienceOn |
7 | Stat B (2011). Neuroblastoma: five-year survival. J Natl Cancer Inst, 103, 1220. DOI ScienceOn |
8 | Sung KW, Ahn HS, Cho B, et al (2010). Efficacy of tandem high-dose chemotherapy and autologous stem cell rescue in patients over 1 year of age with stage 4 neuroblastoma: the Korean Society of Pediatric Hematology-Oncology experience over 6 years (2000-2005). J Korean Med Sci, 25, 691-7. DOI ScienceOn |
9 | Tan C, Sabai SM, Tin AS, Quah TC, Aung L (2012), Neuroblastoma: experience from National University Health System, Singapore (1987-2008). Singapore Med J, 53, 19-25. |
10 | Vermeulen J, De Preter K, Naranjo A, et al (2009). Outcome Prediction of children with neuroblastoma using a multigene expression signature, a retrospective SIOPEN/COG/GPOH study. Lancet Oncol, 10, 663-71. DOI ScienceOn |
11 | Weinstein JL, Katzenstein HM, Cohn SL (2003). Advances in the diagnosis and treatment of neuroblastoma. Oncologist, 8, 278-92. DOI ScienceOn |
12 | Wiangnon S, Veerakul G, Nuchprayoon I, et al (2011). Childhood cancer incidence and survival 2003-2005, Thailand: study from the Thai pediatric oncology group. Asian Pac J Cancer Prev, 12, 2215-20. |
13 | Chen QR, Song YK, Wei JS, et al (2008). An integrated crossplatform prognosis study on neuroblastoma patients. Genomics, 92, 195-203. DOI ScienceOn |
14 | Bernstein ML, Leclerc JM, Bunin G, et al (1992). A populationbased study of neuroblastoma incidence, survival, and mortality in North America. J Clin Oncol, 10, 323-9. |
15 | Bhatnagar SN, Sarin YK (2012). Neuroblastoma: a review of management and outcome. Indian J Pediatrics, 79, 787-92. DOI ScienceOn |
16 | Brodeur GM (2011). Knowing your ABCCs: novel functions of ABCC transporters. J Natl Cancer Inst, 103, 1207-8. DOI ScienceOn |
17 | Cornero A, Acquaviva M, Fardin P, et al (2012). Design of a multi-signature ensemble classifier predicting neuroblastoma patients' outcome. BMC Bioinformatics, 13, 13. DOI ScienceOn |
18 | David L, Baker MLS, Susan L, et al (2010). Outcome after reduced chemotherapy for intermediate-risk neuroblastoma. N Engl J Med, 363, 1313-23. DOI ScienceOn |
19 | Hara J ( 2012). Development of treatment strategies for advanced neuroblastoma. Int J Clinical Oncology, 17, 196-203. DOI ScienceOn |
![]() |